GMP-certified analysis and quality control for Transdermal Drug Delivery Systems (TDDS), ensuring regulatory compliance and dosage precision.
Transdermal patches require a unique fusion of adhesive science and pharmaceutical precision. At BrownBiology Laboratory, we provide specialized QC programs mapping the entire lifecycle of transdermal products.
Our laboratories are equipped with dedicated dissolution apparatus and skin permeation modules to execute complex in-vitro release (IVRT) and permeation (IVPT) studies, alongside rigorous physical testing for patch integrity.
Consult Our Specialists 鈫?/a>
Comprehensive testing protocols for transdermal drug delivery excellence.
Critical assessment of peel adhesion, tack properties, and shear strength to ensure reliable patch performance and patient wearability.
Standardized drug release profiles using USP Apparatus 5 (Paddle over Disk), 6 (Cylinder), or 7 (Reciprocating Holder) across all product formats.
Simulating drug delivery through skin barriers using Franz diffusion cells to quantify biological availability and absorption kinetics.
Monitoring of related substances and potential degradation pathways through high-resolution HPLC-UV/MS modules during stability trials.
We support transdermal programs from early stage method development and validation through to long-term stability monitoring and late-stage clinical batch release. Our data packages are fully structured for IND/NDA and market authorization dossiers.